Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder

B. A. Fallon, R. Campeas, F. R. Schneier, Eric Hollander, J. Feerick, J. Hatterer, D. Goetz, S. Davies, M. R. Liebowitz

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

In a preliminary trial, five oral-clomipramine-refractory patients with obsessive-compulsive disorder (OCD) were treated openly with 14 intravenous clomipramine infusions each. Using standardized assessments, three patients were rated as much improved, one as unchanged, and one as minimally improved. Statistically significant improvements were noted on both the Yale-Brown Obsessive Compulsive Scale and the NIMH Global OCD scores. No patient discontinued treatment because of side effects. Although the results are provocative in that three of five patients were much improved at the end of the protocol, conclusions about preferential efficacy for the intravenous route must await a placebo-controlled trial.

Original languageEnglish (US)
Pages (from-to)70-75
Number of pages6
JournalJournal of Neuropsychiatry and Clinical Neurosciences
Volume4
Issue number1
StatePublished - 1992
Externally publishedYes

Fingerprint

Clomipramine
Obsessive-Compulsive Disorder
National Institute of Mental Health (U.S.)
Therapeutics
Intravenous Infusions
Placebos

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder. / Fallon, B. A.; Campeas, R.; Schneier, F. R.; Hollander, Eric; Feerick, J.; Hatterer, J.; Goetz, D.; Davies, S.; Liebowitz, M. R.

In: Journal of Neuropsychiatry and Clinical Neurosciences, Vol. 4, No. 1, 1992, p. 70-75.

Research output: Contribution to journalArticle

Fallon, BA, Campeas, R, Schneier, FR, Hollander, E, Feerick, J, Hatterer, J, Goetz, D, Davies, S & Liebowitz, MR 1992, 'Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder', Journal of Neuropsychiatry and Clinical Neurosciences, vol. 4, no. 1, pp. 70-75.
Fallon, B. A. ; Campeas, R. ; Schneier, F. R. ; Hollander, Eric ; Feerick, J. ; Hatterer, J. ; Goetz, D. ; Davies, S. ; Liebowitz, M. R. / Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder. In: Journal of Neuropsychiatry and Clinical Neurosciences. 1992 ; Vol. 4, No. 1. pp. 70-75.
@article{78c5d6c51c95446c8e3ac79ecbd1a86c,
title = "Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder",
abstract = "In a preliminary trial, five oral-clomipramine-refractory patients with obsessive-compulsive disorder (OCD) were treated openly with 14 intravenous clomipramine infusions each. Using standardized assessments, three patients were rated as much improved, one as unchanged, and one as minimally improved. Statistically significant improvements were noted on both the Yale-Brown Obsessive Compulsive Scale and the NIMH Global OCD scores. No patient discontinued treatment because of side effects. Although the results are provocative in that three of five patients were much improved at the end of the protocol, conclusions about preferential efficacy for the intravenous route must await a placebo-controlled trial.",
author = "Fallon, {B. A.} and R. Campeas and Schneier, {F. R.} and Eric Hollander and J. Feerick and J. Hatterer and D. Goetz and S. Davies and Liebowitz, {M. R.}",
year = "1992",
language = "English (US)",
volume = "4",
pages = "70--75",
journal = "Journal of Neuropsychiatry and Clinical Neurosciences",
issn = "0895-0172",
publisher = "American Psychiatric Publishing Inc.",
number = "1",

}

TY - JOUR

T1 - Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder

AU - Fallon, B. A.

AU - Campeas, R.

AU - Schneier, F. R.

AU - Hollander, Eric

AU - Feerick, J.

AU - Hatterer, J.

AU - Goetz, D.

AU - Davies, S.

AU - Liebowitz, M. R.

PY - 1992

Y1 - 1992

N2 - In a preliminary trial, five oral-clomipramine-refractory patients with obsessive-compulsive disorder (OCD) were treated openly with 14 intravenous clomipramine infusions each. Using standardized assessments, three patients were rated as much improved, one as unchanged, and one as minimally improved. Statistically significant improvements were noted on both the Yale-Brown Obsessive Compulsive Scale and the NIMH Global OCD scores. No patient discontinued treatment because of side effects. Although the results are provocative in that three of five patients were much improved at the end of the protocol, conclusions about preferential efficacy for the intravenous route must await a placebo-controlled trial.

AB - In a preliminary trial, five oral-clomipramine-refractory patients with obsessive-compulsive disorder (OCD) were treated openly with 14 intravenous clomipramine infusions each. Using standardized assessments, three patients were rated as much improved, one as unchanged, and one as minimally improved. Statistically significant improvements were noted on both the Yale-Brown Obsessive Compulsive Scale and the NIMH Global OCD scores. No patient discontinued treatment because of side effects. Although the results are provocative in that three of five patients were much improved at the end of the protocol, conclusions about preferential efficacy for the intravenous route must await a placebo-controlled trial.

UR - http://www.scopus.com/inward/record.url?scp=0026562368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026562368&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 70

EP - 75

JO - Journal of Neuropsychiatry and Clinical Neurosciences

JF - Journal of Neuropsychiatry and Clinical Neurosciences

SN - 0895-0172

IS - 1

ER -